Skip to content

Assessing Lower Extremity Dynamic Stability in Middle-Aged and Elderly Patients With Patellofemoral Pain Using the Y-Balance Test

Assessing Lower Extremity Dynamic Stability in Middle-Aged and Elderly Patients With Patellofemoral Pain Using the Y-Balance Test: A Cross-Sectional Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07068984
Enrollment
70
Registered
2025-07-16
Start date
2025-03-01
Completion date
2025-04-10
Last updated
2025-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellofemoral Pain Syndrome, Y-balance

Brief summary

Background: Patellofemoral pain syndrome (PFPS) is a common functional disorder of knee joint. Its etiology involves biomechanical abnormalities and dynamic stability defects. Most of the existing studies focus on young people, and the biomechanical characteristics and functional compensation mechanism of middle-aged and elderly patients are still unclear. The Y-Balance test is becoming an important tool in PFPS research because of its sensitivity to assess the dynamic balance ability of lower limbs. Objective: To analyze the functional characteristics of lower limbs of PFPS patients aged 40-60 by Y-Balance test, and to explore the differences between PFPS patients and healthy people, so as to provide evidence for clinical rehabilitation. Methods: A cross-sectional observational study was conducted in 49 PFPS patients and 21 healthy controls. Y-Balance test was used to evaluate bilateral forward difference, composite score, lateral and posterior balance, symmetry ratio and bilateral difference. SPSS 25.0 was used for statistical analysis.

Interventions

OTHERDifferences between lower limb balances were assessed by the Y-Balance test

The Y-Balance test was used to evaluate bilateral anterior difference, composite score, lateral and posterior balance, symmetry ratio and bilateral difference

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
40 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Aged between 40 and 60 years * Clinically diagnosed with patellofemoral pain (PFP) with symptoms lasting ≥3 months * No other serious lower extremity disorders * No neurological diseases * No history of recent lower extremity surgery (\<12 months) * No history of major lower extremity trauma * Control group: Age- and sex-matched healthy volunteers without knee pain or lower limb dysfunction

Exclusion criteria

Acute inflammatory conditions Meniscus injury Knee ligament injury Intra-articular fracture Bone tumor Bone tuberculosis Neurovascular injury including: 1. Stroke history 2. Parkinson's disease Subjective unwillingness to comply with testing Inability to complete Y-Balance Test Serious systemic diseases affecting: Cardiovascular system Hepatic function Renal function Hematological system

Design outcomes

Primary

MeasureTime frameDescription
Analysis of Y-balance characteristics of patellofemoral pain syndromeBaselineOutcome Measure Title:Y-Balance Test (YBT) Reach Distance (cm) - Comparison between Patellofemoral Pain Syndrome (PFPS) Patients (Aged 40-60 Years) and Healthy Controls Outcome Measure Description:The Y-Balance Test (YBT) was used to assess dynamic balance function of the lower limbs in participants. Metrics Measured: The maximum reach distance (in centimeters, cm) achieved by participants in three directions (Anterior, Posteromedial, Posterolateral) during single-leg stance. Data Summary:The average maximum reach distance (cm) from three valid trials was calculated for each direction, separately for the left and right legs. Comparative Analysis: The average maximum reach distance (cm) in each direction for the left and right legs in the PFPS patient group (aged 40-60 years) were compared with the corresponding metrics in an age- and sex-matched group of healthy controls to analyze between-group differences.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026